» Articles » PMID: 20005852

Revealing Global Regulatory Perturbations Across Human Cancers

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2009 Dec 17
PMID 20005852
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of pathways and regulatory networks whose perturbation contributes to neoplastic transformation remains a fundamental challenge for cancer biology. We show that such pathway perturbations, and the cis-regulatory elements through which they operate, can be efficiently extracted from global gene expression profiles. Our approach utilizes information-theoretic analysis of expression levels, pathways, and genomic sequences. Analysis across a diverse set of human cancers reveals the majority of previously known cancer pathways. Through de novo motif discovery we associate these pathways with transcription-factor binding sites and miRNA targets, including those of E2F, NF-Y, p53, and let-7. Follow-up experiments confirmed that these predictions correspond to functional in vivo regulatory interactions. Strikingly, the majority of the perturbations, associated with putative cis-regulatory elements, fall outside of known cancer pathways. Our study provides a systems-level dissection of regulatory perturbations in cancer-an essential component of a rational strategy for therapeutic intervention and drug-target discovery.

Citing Articles

HP-Bodies - Ancestral Condensates that Regulate RNA Turnover and Protein Translation in Bacteria.

Guan J, Hurto R, Rai A, Azaldegui C, Ortiz-Rodriguez L, Biteen J bioRxiv. 2025; .

PMID: 39975000 PMC: 11839049. DOI: 10.1101/2025.02.06.636932.


DNA methylation affects gene expression but not global chromatin structure in .

Morgan W, Amemiya H, Freddolino L bioRxiv. 2025; .

PMID: 39829790 PMC: 11741368. DOI: 10.1101/2025.01.06.631547.


A generative framework for enhanced cell-type specificity in rationally designed mRNAs.

Khoroshkin M, Zinkevich A, Aristova E, Yousefi H, Lee S, Mittmann T bioRxiv. 2025; .

PMID: 39803435 PMC: 11722239. DOI: 10.1101/2024.12.31.630783.


Identification and genetic dissection of convergent persister cell states.

Blattman S, Jiang W, McGarrigle E, Liu M, Oikonomou P, Tavazoie S Nature. 2024; 636(8042):438-446.

PMID: 39506104 PMC: 11634777. DOI: 10.1038/s41586-024-08124-2.


A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation.

Ge A, Arab A, Dai R, Navickas A, Fish L, Garcia K Sci Rep. 2024; 14(1):25940.

PMID: 39472491 PMC: 11522420. DOI: 10.1038/s41598-024-77314-9.


References
1.
Elemento O, Tavazoie S . Fast and systematic genome-wide discovery of conserved regulatory elements using a non-alignment based approach. Genome Biol. 2005; 6(2):R18. PMC: 551538. DOI: 10.1186/gb-2005-6-2-r18. View

2.
Cutroneo K, Ehrlich H . Silencing or knocking out eukaryotic gene expression by oligodeoxynucleotide decoys. Crit Rev Eukaryot Gene Expr. 2006; 16(1):23-30. DOI: 10.1615/critreveukargeneexpr.v16.i1.20. View

3.
Facchinetti V, Lopa R, Spreafico F, Bolognese F, Mantovani R, Tavner F . Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1. Oncogene. 2000; 19(34):3931-40. DOI: 10.1038/sj.onc.1203730. View

4.
Griffiths-Jones S, Saini H, van Dongen S, Enright A . miRBase: tools for microRNA genomics. Nucleic Acids Res. 2007; 36(Database issue):D154-8. PMC: 2238936. DOI: 10.1093/nar/gkm952. View

5.
Duncan T, Al-Attar A, Rolland P, Scott I, Deen S, Liu D . Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?. Clin Cancer Res. 2008; 14(10):3030-5. DOI: 10.1158/1078-0432.CCR-07-1888. View